BIO-TECHNE Corp
BIO-TECHNE Corp
MINNEAPOLIS, MN
Loading...
Price History
Market Data
| Market Cap | 7.55B |
| P/E Ratio | 94.96 |
| P/B Ratio | 3.75 |
| EPS | 0.51 |
| Dividend Yield | - |
| D/E Ratio | - |
| Current Ratio | 4.54 |
| Currency | USD |
Key Financial Metrics
1.22B
Revenue
81.10M
Net Income
0.51
EPS (Diluted)
377.48M
Free Cash Flow
Profitability
Gross Margin
65.2%
Operating Margin
9.6%
Net Profit Margin
6.7%
EBITDA
300.26M
Returns & Efficiency
Return on Assets (ROA)
3.2%
Return on Equity (ROE)
4.0%
Dividend Yield
-
EPS
0.51
Financial Health
Total Assets
2.52B
Total Debt
260.00M
Debt to Equity
-
Current Ratio
4.54
Insider Trading
Last 12 months
0
Buys
0
Sells
0
Insiders
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
| Industry | Chemicals & Allied Products |
| HQ | MINNEAPOLIS, MN |
| Fiscal Year | 2025 |
Peers
AMGEN INC
AMGN
178.46B
P/E: --
GILEAD SCIENCES INC
GILD
162.80B
P/E: --
162.80B
P/E: --
BIOGEN IDEC INC.
BIIB
28.41B
P/E: --
BIOGEN INC.
BIIB
28.41B
P/E: --
MODERNA, INC.
MRNA
21.50B
P/E: --
Moderna, Inc.
MRNA
21.50B
P/E: --
19.11B
P/E: --
Quick Links
Financial Statistics
Valuation
Market Cap$7.55B
P/E Ratio (TTM)95.0
Price to Book3.75
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin65.2%
Operating Margin9.6%
Net Margin6.7%
ROE4.0%
ROA3.2%
Leverage & Liquidity
Debt to Equity-
Current Ratio4.54
Total Debt$260.00M
Total Assets$2.52B
Stockholders' Equity$2.01B
Income Statement (FY 2025)
Revenue$1.22B
Gross Profit$792.76M
Operating Income$116.97M
Net Income$81.10M
EPS (Diluted)$0.51
Cash Flow (FY 2025)
Free Cash Flow$377.48M
Cash & Equivalents$172.88M
Revenue Growth-0.3%
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address | 614 MCKINLEY PL N E SUITE 1500 MINNEAPOLIS, MN 55413 |
| Phone | N/A |
| Incorporated | MN, US |
| EIN | 411427402 |
| Fiscal Year End | 0630 |
| Shares Outstanding | 155.84M |
| Stockholders' Equity | $2.01B |
| Cash & Equivalents | $172.88M |
Recent Filings
View All
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-05-07
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-05-07
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-05-07
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-05-06
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2026-05-06
Local
SCHEDULE 13G
Passive Ownership Report
Schedule 13G - passive beneficial ownership
Filed: 2026-05-06
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-05-05
Local
SCHEDULE 13G
Passive Ownership Report
Schedule 13G - passive beneficial ownership
Filed: 2026-04-29
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-16
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-07
Local
SCHEDULE 13G/A
Amended Schedule 13G
Amendment to Schedule 13G
Filed: 2026-03-26
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-04
Local
3
Initial Ownership Report
Initial statement of beneficial ownership of securities
Filed: 2026-03-04
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-02-17
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-02-11
Local
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...
Loading...
Loading short interest data...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
| Company Name | BIO-TECHNE Corp |
| Ticker | TECH |
| Exchange | -- |
| Sector | Manufacturing |
| Industry | Chemicals & Allied Products |
| Headquarters | MINNEAPOLIS, MN |
| Fiscal Year | 2025 |
Financial Summary
| Market Cap | 7.55B |
| Revenue | 1.22B |
| Net Income | 81.10M |
| P/E Ratio | 94.96 |
| EPS | 0.51 |
| Net Margin | 6.7% |
| ROE | 4.0% |
| Dividend Yield | - |
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...